Treatment of Chronic Hepatitis C in the Aged – Does It Impact Life Expectancy? A Decision Analysis

Open Access

Peer-reviewed

Research Article

Yaakov Maor ,

* E-mail: yaakovma1@clalit.org.il

Affiliation Institute of Gastroenterology and Hepatology, Kaplan Medical Center, Rehovot, Israel
⨯
Stephen D. H. Malnick,

Affiliations Institute of Gastroenterology and Hepatology, Kaplan Medical Center, Rehovot, Israel, Department of Internal Medicine C, Kaplan Medical Center, Rehovot, Israel
⨯
Ehud Melzer,

Affiliation Institute of Gastroenterology and Hepatology, Kaplan Medical Center, Rehovot, Israel
⨯
Moshe Leshno

Affiliation Faculty of Management and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⨯

Reader Comments (0)

Fibrosis
Is the Subject Area "Fibrosis" applicable to this article?

Thanks for your feedback.
Life expectancy
Is the Subject Area "Life expectancy" applicable to this article?

Thanks for your feedback.
Liver transplantation
Is the Subject Area "Liver transplantation" applicable to this article?

Thanks for your feedback.
Protease inhibitor therapy
Is the Subject Area "Protease inhibitor therapy" applicable to this article?

Thanks for your feedback.
Cirrhosis
Is the Subject Area "Cirrhosis" applicable to this article?

Thanks for your feedback.
Hepatitis C virus
Is the Subject Area "Hepatitis C virus" applicable to this article?

Thanks for your feedback.
Geriatric care
Is the Subject Area "Geriatric care" applicable to this article?

Thanks for your feedback.
Hepatocellular carcinoma
Is the Subject Area "Hepatocellular carcinoma" applicable to this article?

Thanks for your feedback.